Preserving insulin production in people with newly diagnosed type 1 diabetes
Researchers have discovered that treatment with a medicine that suppresses the immune system, called anti-thymocyte globulin (ATG), preserved insulin production and improved blood glucose (sugar) control for at least a year in people with newly diagnosed type 1 diabetes, as compared to placebo (no medicine).  (Source: NIDDK News)
Source: NIDDK News - March 22, 2019 Category: Endocrinology Source Type: news

Lian receives ENGINE grant for stem-cell-based diabetes therapy
(Penn State) Xiaojun 'Lance' Lian, assistant professor of biomedical engineering, was one of three recipients of the College of Engineering's ENGineering for Innovation& Entrepreneurship (ENGINE) grant for 'Small Molecule-Based Definitive Endoderm Kit and Pancreatic Progenitor Kit for Stem Cell Research and Therapy.' The project focuses on differentiating stem cells into pancreatic beta cells to be used for therapies to treat Type 1 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news

EOFlow wins breakthrough status for wearable closed-loop insulin delivery tech
Korean medtech company EOFlow said last week that it won breakthrough status from the FDA for its closed-loop automated insulin delivery system for people with Type 1 diabetes. The EOPancreas system features a wearable patch, continuous glucose monitoring systems and a closed-loop blood glucose control algorithm. Get the full story at our sister site, Drug Delivery Business News. The post EOFlow wins breakthrough status for wearable closed-loop insulin delivery tech appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 19, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Featured Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance eoflow Source Type: news

Preserving insulin production in people with newly diagnosed type 1 diabetes
Researchers have discovered that treatment with a medicine that suppresses the immune system, called anti-thymocyte globulin (ATG), preserved insulin production and improved blood glucose (sugar) control for at least a year in people with newly diagnosed type 1 diabetes, as compared to placebo (no medicine).  (Source: NIDDK News)
Source: NIDDK News - March 19, 2019 Category: Endocrinology Source Type: news

Nose examination provides clues to lung infection
Bacteria and viruses in the nose was altered in children with severe infection Related items fromOnMedica Rapid rise in flu consultations putting strain on GPs Adjuvanted trivalent flu vaccine best option for over-65s Pay more heed to parent concern over sick children Improve uptake of MMR jab to meet WHO target Recurrent viral RTIs in first 6 months linked to type 1 diabetes risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 18, 2019 Category: UK Health Source Type: news

Emotional Support Key to Unlocking Eating Disorders in T2D Emotional Support Key to Unlocking Eating Disorders in T2D
Eating disorders, which are common in type 1 and type 2 diabetes and can have devastating consequences, need an emphasis on emotional support if outcomes are to be improved, say UK experts.Medscape News UK (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 15, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Xeris launches Ph2 trial of ready-to-use liquid glucagon
Xeris Pharmaceuticals (NSDQ:XERS) said today that it dosed the first patients in a Phase II trial of its ready-to-use liquid glucagon in people with Type 1 diabetes. The Chicago-based company expects to report top-line data from the study in the second half of 2019. Get the full story at our sister site, Drug Delivery Business News. The post Xeris launches Ph2 trial of ready-to-use liquid glucagon appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 15, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Diabetes Drug-Device Combinations Featured Pharmaceuticals Wall Street Beat xerispharmaceuticals Source Type: news

C-Peptide Test Should Be the Norm After Type 1 Diabetes C-Peptide Test Should Be the Norm After Type 1 Diabetes
Using a more convenient, cheaper C-peptide test a few years after diagnosis of type 1 diabetes can help pinpoint occasional patients who have been misdiagnosed.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Lack of Access to Type 1 Diabetes Technology'Unacceptable'Lack of Access to Type 1 Diabetes Technology'Unacceptable '
Type 1 diabetes patients in England and Wales face inequitable access to technologies such as continuous glucose monitoring which is leaving less than one third at HbA1c targets, warn experts.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

23andMe Has a New Type 2 Diabetes Risk Report. Here ’s What to Know
Consumer genetics company 23andMe is broadening its health portfolio with a new report on consumers’ genetic risk of developing Type 2 diabetes. More than 30 million Americans have diagnosed or undiagnosed diabetes, according to the most recent federal data. The vast majority of these people — up to 95% — have Type 2 diabetes, meaning their bodies do not use insulin properly. Both Type 1 and Type 2 diabetes are related to family history and genetics, but Type 2 is also strongly associated with obesity, as well as lifestyle factors such as diet and exercise. The new 23andMe report estimates a customer&rsq...
Source: TIME: Health - March 11, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Research Source Type: news

Gluten Intake in Toddlers Not Tied to Risk of Progression to Type 1 Diabetes Gluten Intake in Toddlers Not Tied to Risk of Progression to Type 1 Diabetes
Gluten intake is not associated with islet autoimmunity or progression to type 1 diabetes in high-risk older infants and toddlers, according to results from the DAISY study.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 8, 2019 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news

Type 2 Diabetes Ups Odds of VTE, Metformin Reduces It Type 2 Diabetes Ups Odds of VTE, Metformin Reduces It
In a new study, VTE was nearly three times as common in type 2 diabetes as in type 1 or in people without diabetes. And metformin reduced the risk of VTE.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 8, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Cost Savings Make Case for CGM Roll-out for T1D in Pregnancy Cost Savings Make Case for CGM Roll-out for T1D in Pregnancy
Offering continuous glucose monitoring to pregnant women with type 1 diabetes will not only improve clinical outcomes but lead to substantial savings in healthcare budgets, argue UK clinicians.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 8, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

A Gulp Of Genetically Modified Bacteria Might Someday Treat A Range Of Illnesses
Researchers think genetically engineered versions of microbes that can live in humans could help treat some rare genetic disorders and perhaps help with Type 1 diabetes, cirrhosis and cancer.(Image credit: Julia Ritchey/KUER) (Source: NPR Health and Science)
Source: NPR Health and Science - March 8, 2019 Category: Consumer Health News Authors: Rob Stein Source Type: news

Bariatric surgery could reduce heart disease risk in diabetics
Diabetics 70% less likely to develop dangerous heart disease Related items fromOnMedica Early age type 1 diabetes linked to shorter life expectancy than later age diagnosis Experts warn of heart risks for people with diabetes Chocolate could prevent some CVD events Shocking variation in diabetes care across UK Less than half of patients accept NHS Health Check (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 8, 2019 Category: UK Health Source Type: news

Guidance on flash glucose monitors for type 1 diabetes
Tens of thousands of patients with type 1 diabetes will benefit from life changing glucose monitors on the NHS from next month. (Source: NHS Networks)
Source: NHS Networks - March 8, 2019 Category: UK Health Source Type: news

AI Used to ID Risk of Heart Disease in Diabetes Study
Artificial intelligence is constantly being used in new and different applications in healthcare. A research team from the University of Gothenburg, is now using the power of AI in combination with conventional statistical methods in a study of risk factors in type 1 diabetes. The study’s objective was to identify the most important indicators of elevated risk for cardiovascular disease and death. "What's unique about this study is that we've included machine learning analyses - that is, algorithms for AI - to assess strength of association for cardiovascular risk factors," Aidin Rawshani, PhD, ...
Source: MDDI - March 7, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Digital Health Source Type: news

Guidance released on roll out of digital glucose monitors in England
Clinical guidance has been published to support the roll out of digital glucose monitors on the NHS for patients with type 1 diabetes in England. (Source: Nursing Times)
Source: Nursing Times - March 7, 2019 Category: Nursing Source Type: news

Ohio State ’s research making strides in diabetes treatment
One in 10 Americans has diabetes, and one in three is on their way to developing it. But through leading-edge clinical trials, researchers at The Ohio State University Wexner Medical Center are working toward a future without diabetes. Experts within Ohio State’s Diabetes and Metabolism Research Center are focused on diabetes (both Type 1 and Type 2), endocrinology and metabolism, and advancing care for those with diabetes. Specialists provide consultation services and education programs for patients,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 6, 2019 Category: Biotechnology Authors: The Ohio State University Wexner Medical Center Source Type: news

AI study of risk factors in type 1 diabetes
The objective was to identify the most important indicators of elevated risk for cardiovascular disease and death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2019 Category: International Medicine & Public Health Source Type: news

Novel treatments offer new hope for patients with autoimmune disease
Autoimmune diseases, including type 1 diabetes and multiple sclerosis, arise when the body's immune cells attack itself. Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections. Researchers at University of Utah Health have developed a new approach that targets the misfunctioning immune cells while leaving normal immune cells in place. (Source: World Pharma News)
Source: World Pharma News - March 5, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Medical News Today: 'Taking treatment for autoimmune disease in a new direction'
Could a newly devised therapy pave the way toward better, less risky treatments for autoimmune conditions such as multiple sclerosis and type 1 diabetes? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 5, 2019 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

EU Panel OKs Sotagliflozin for Some With Type 1 Diabetes EU Panel OKs Sotagliflozin for Some With Type 1 Diabetes
The decision includes a list of requirements for use of the SGLT1/ SGLT2 inhibitor in select patients to minimize DKA risk. The EU approval will be the first worldwide for sotagliflozin.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 1, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

Coping With Diabetes Is a Family Affair
FRIDAY, March 1, 2019 -- When Giuseppina Miller's 8-year-old son, Peter, was first diagnosed with type 1 diabetes, he necessarily got a lot of his parents'attention. " We tried to adjust pretty well, but I was getting no sleep because I had to check... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2019 Category: General Medicine Source Type: news

Diabulimia: NHS cash to treat type 1 diabetes eating disorder
Zohra says treatment for the type 1 diabetes eating disorder has saved her life. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 28, 2019 Category: Consumer Health News Source Type: news

Herbalist sentenced after death of diabetic boy advised not to use insulin
An herbalist has been sentenced to jail time after the death of a 13-year-old boy with Type 1 diabetes for whom he recommended treatment with herbs instead of lifesaving insulin, Los Angeles City Attorney Mike Feuer announced Monday. (Source: CNN.com - Health)
Source: CNN.com - Health - February 28, 2019 Category: Consumer Health News Source Type: news

Depression and suicide screening in adolescents with Type 1 diabetes: 5-years of implementation and outcomes - Corathers S, Mara CA, Chundi PK, Kichler JC.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - February 27, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Patient Selection Key to DKA Prevention With SGLT Inhibitors in Type 1 Diabetes Patient Selection Key to DKA Prevention With SGLT Inhibitors in Type 1 Diabetes
Selection of appropriate patients for sodium-glucose cotransporter (SGLT)-inhibitor therapy is"critical" to minimizing the risk of diabetic ketoacidosis (DKA), an expert panel advises in a new consensus report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 26, 2019 Category: Pathology Tags: Diabetes & Endocrinology News Source Type: news

A Guide to Improving Insulin Access for Patients With T1D A Guide to Improving Insulin Access for Patients With T1D
Dr Tridgell is an active advocate for affordable access to insulin. Here, he lays out concrete steps clinicians can take to improve insulin access for patients with type 1 diabetes.Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Article Source Type: news

New therapy approach may improve diabetes treatment
Research, published inCell Metabolism, suggests that eliminating damaged beta cells that can no longer produce insulin may be an effective treatment for type-1 diabetes. Independant (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 22, 2019 Category: Endocrinology Source Type: news

Gut viruses may increase diabetes risk
Research, published inScientific Reports, suggests that high levels of intestinal enteroviruses may increase type-1 diabetes risk in children.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 22, 2019 Category: Endocrinology Source Type: news

Nanotechnology breakthrough helps diabetics track their blood sugar levels
(Natural News) Patients with Type 1 diabetes can thank Oregon-based researchers for developing a wearable medical device that works like an artificial pancreas. 3D printed instead of built, its nano sensors keep a constant eye on blood glucose levels, so that it can deliver insulin and glucagon to the patient whenever necessary. The new device was designed by researchers... (Source: NaturalNews.com)
Source: NaturalNews.com - February 22, 2019 Category: Consumer Health News Source Type: news

Viruses that linger in the gut could trigger type 1 diabetes
(Columbia University's Mailman School of Public Health) Researchers at the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and the University of New South Wales, Sydney, Australia, provide new evidence supporting an association between elevated levels of enteroviruses in the intestinal tracts of children and islet autoimmunity, a precursor to type 1 diabetes. The paper appears in the journal Scientific Reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

Engineered 'suicide genes' prevent tumors in stem cell-derived beta cells
(Diabetes Research Institute Foundation) Scientists from the Diabetes Research Institute at the University of Miami have engineered a human pluripotent stem cell line containing two 'suicide genes' that induce cell death in all but the desired insulin-producing cells. This double fail-safe approach addresses the limitations of pluripotent stem cell-derived beta cells and opens the door to creating safe cell-replacement therapies for people living with type 1 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2019 Category: International Medicine & Public Health Source Type: news

Improved model of type-1 diabetes
A new mouse model of type-1 diabetes has been developed that may help researchers to better study the disease, according to research published inScientific Reports.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 13, 2019 Category: Endocrinology Source Type: news

Diabetes Eye Exam Frequency in US Is'Alarmingly Low'Diabetes Eye Exam Frequency in US Is'Alarmingly Low '
In a large database of insured patients, almost half with type 2 diabetes and a third with type 1 diabetes had no eye exam in a 5-year period. Change is needed to stop retinopathy being the leading cause of blindness.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

The diabetics who’ve made their own new pancreas 
Like all of the 460,000 Brits with type 1 diabetes, Tim Street, has to constantly monitor his blood sugar levels and inject insulin many times a day to stay alive. But a new treatment has changed this. (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2019 Category: Consumer Health News Source Type: news

Blood sugar tied to fracture risk in type 1 diabetes
(Reuters Health) - People with type 1 diabetes are more likely to break a bone when their average blood sugar levels are dangerously high, a large study suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Diabetes does not appear to affect children's test scores
(Reuters Health) - Kids living with type 1 diabetes are no different from their peers in their reading and math test scores, a Danish study suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Researchers Are Working on a Surprising Way to Deliver Insulin Without an Injection: Swallowing the Needle
Needles aren’t popular. For people with type 1 diabetes (and some with type 2 diabetes) that can be a problem, since treatment requires regular injections with insulin. Now, researchers at MIT have come up with a novel way to one day eliminate the need for injections: with a tiny swallowable device that can automatically inject insulin directly into the stomach wall. In a report published in Science, Robert Langer and Giovanni Traverso describe what they call a self-orienting millimeter scale applicator, or SOMA, that they developed to make injecting drugs easier. So far, SOMA has only been tested in animals. Roughly...
Source: TIME: Health - February 7, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized diabetes healthytime Source Type: news

Type-1 diabetes does not affect school performance in children
Research, published inJAMA, suggests that childhood reading and maths skills are unaffected by type-1 diabetes.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 6, 2019 Category: Endocrinology Source Type: news

Children with diabetes perform well in school
(Aarhus University) On average, Danish children suffering from type 1 diabetes perform just as well in school as their classmates. This is the result of the largest study so far exploring how children with diabetes perform in school. The study was conducted at Aarhus BSS in collaboration with Danish and international researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Reading, Math Scores No Different for Children With T1DM
TUESDAY, Feb. 5, 2019 -- Standardized reading and mathematics scores do not differ significantly for public schoolchildren with and without type 1 diabetes, according to a study published in the Feb. 5 issue of the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2019 Category: Pharmaceuticals Source Type: news

Type 1 Diabetes May Not Impair School Performance in Kids Type 1 Diabetes May Not Impair School Performance in Kids
Danish population-based study finds no differences in reading and math scores among children with diabetes compared to those without, but glycemic control does make a difference.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Insulin-producing cells grown in lab may be type 1 diabetes breakthrough
A new, effective alternative to pancreas tranplantation may be on the horizon to treat type 1 diabetes, a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 5, 2019 Category: Consumer Health News Source Type: news

Is type 1 diabetes associated with poorer performance in school by children?
(JAMA Network) This observational study compared standardized test scores in reading and math for more than 630,000 Danish public school children with and without type 1 diabetes. Researchers found no significant difference in reading and math scores between the groups of children who were attending second, third, fourth, sixth and eighth grades in Denmark.   The findings may not apply to other countries. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 5, 2019 Category: International Medicine & Public Health Source Type: news

Go ahead for first add-on tablet to insulin treatment for type 1 diabetes
European regulator recommends dapagliflozin for those with poor blood glucose control despite best efforts Related items fromOnMedica Use of DPP-4 inhibitors associated with increased risk of IBD Adding insulin to metformin linked to higher mortality Draft diabetes guidance too heavily focused on cost, protests industry MHRA tightens licence restrictions on valproate for women Withdrawn valsartan meds not linked to short-term cancer risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 5, 2019 Category: UK Health Source Type: news

Hope for diabetics as scientists turn stem cells into ones that can produce insulin
Researchers in California created healthy beta cells, which are destroyed in type 1 diabetics. They produced insulin and responded to sugar within three days in mice tests. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2019 Category: Consumer Health News Source Type: news

Islet cell transplants into the retina may induce immune tolerance
Research, published inDiabetologia, suggests that transplantation of insulin producing islet cells into the retina may induce immune tolerance, which may remove the need for anti-rejection therapies in type-1 diabetes patients.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 4, 2019 Category: Endocrinology Source Type: news

Insulin-producing cells may be present in early stages of type-1 diabetes
Research, published inCell Metabolism, suggests that insulin-producing beta cells are still present in the early stages of type-1 diabetes, which may be targetable to help treat the disease.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 4, 2019 Category: Endocrinology Source Type: news